// App-Quantinova.ai

P1-01-14 : Nuclease-activated oligonucleotide probes for detection of breast cancer circulating tumor cells (CTCs): Early clinical results

Researchers

Presenter

  • PH Giangrande

Principal Investigators

  • S Kruspe

  • DD Dickey

  • S Kamboj

  • KC Clark

  • K Urak

  • E Burghardt

  • B Smith

  • A Thomas

  • JO McNamara

Medical Centers

  • University of Iowa, Internal Medicine, Iowa City, IA

  • University of Iowa, MCB Program, Iowa City, IA

  • University of Iowa, Biostatistics, Iowa City, IA

  • University of Iowa, MCB Program, Iowa City, IA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Circulating tumor cells

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim